Bevacizumab is a humanized IgG1 monoclonal antibody designed to inhibit vascular endothelial growth factor (VEGF), making it a critical therapeutic agent for treating various malignancies, including colorectal… Read more
Bevacizumab is a humanized IgG1 monoclonal antibody designed to inhibit vascular endothelial growth factor (VEGF), making it a critical therapeutic agent for treating various malignancies, including colorectal and lung cancers, as well as specific ocular conditions like diabetic macular edema. This category offers high-quality reference standards, along with necessary impurities, metabolites, and stable isotope-labelled compounds, which are essential for comprehensive analytical testing. Pharmaceutical laboratories utilize these materials for impurity profiling, method validation, and rigorous quality control protocols to ensure the safety and efficacy of biologic drug products. By providing these specialized reagents, this collection supports precise characterization and ongoing monitoring throughout the drug development lifecycle and regulatory compliance processes.